| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Alnylam Pharmaceuticals, Inc. (ALNY) have been net sellers, shedding 1,758 shares worth roughly $399K on balance. In the past 30 days, 0 insiders bought and 1 sold. The bias lately has been to the sell side.
On the other side, 1 insider reduced a position over the period. ALNY sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 95.8K | - | - | |
| CFO | 64.0K | $20.50M | - | |
| VP | 34.3K | $11.17M | - | |
| VP | 20.7K | $6.73M | - | |
| VP | 19.2K | $6.23M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 2, 2026 | Supran Bryan | EVP, CLO And Secretary | Sell | 1,758 | $226.88 | $398,855.04 | -12.1% | - | - | |
| Jun 1, 2026 | Pyott David E I | Director | Sale+OE | 3,830 | $299.18 | $1,145,852.75 | -70.8% | -18.6% | - | |
| Apr 6, 2026 | McLaughlin Melissa | Chief Human Resources Officer | Sell | 3,910 | $325.92 | $1,274,342.99 | -29.3% | -5.2% | - | |
| Mar 5, 2026 | Fitzgerald Kevin Joseph | CSO &EVP, Head Of Research | Sell | 1,291 | $323.54 | $417,685.48 | -5.9% | -8.8% | - | |
| Mar 5, 2026 | Garg Pushkal50 | EVP Chief R&D | Sell | 4,713 | $323.53 | $1,524,795.55 | -20.1% | -8.8% | - | |
| Mar 4, 2026 | Greenstreet Yvonne49 | Chief Executive Officer | Sell | 2,933 | $323.08 | $947,580.95 | -3.0% | -12.6% | - | |
| Mar 4, 2026 | Poulton Jeffrey V.45 | EVP, Chief Financial Officer | Sell | 2,468 | $323.08 | $797,350.54 | -3.8% | -12.6% | - | |
| Mar 4, 2026 | Tanguler Tolga57 | EVP, Chief Commercial Officer | Sell | 2,309 | $323.08 | $745,983.83 | -6.3% | -12.6% | - | |
| Mar 3, 2026 | Fitzgerald Kevin Joseph | CSO &EVP, Head Of Research | Sell | 1,699 | $319.83 | $543,399.37 | -7.2% | -7.2% | - | |
| Mar 3, 2026 | Garg Pushkal50 | EVP Chief R&D | Sell | 1,922 | $320.09 | $615,218.47 | -7.6% | -7.2% | - |